A detailed history of Empirical Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Empirical Asset Management, LLC holds 7,048 shares of GILD stock, worth $655,957. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,048
Previous 7,048 -0.0%
Holding current value
$655,957
Previous $590,000 10.34%
% of portfolio
0.02%
Previous 0.07%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$63.15 - $72.88 $639,646 - $738,201
-10,129 Reduced 58.97%
7,048 $483,000
Q1 2024

May 10, 2024

BUY
$71.58 - $87.29 $256,327 - $312,585
3,581 Added 26.34%
17,177 $1.26 Million
Q4 2023

Jan 12, 2024

SELL
$73.27 - $83.09 $640,892 - $726,788
-8,747 Reduced 39.15%
13,596 $1.1 Million
Q3 2023

Nov 01, 2023

BUY
$73.94 - $80.67 $59,078 - $64,455
799 Added 3.71%
22,343 $1.67 Million
Q2 2023

Aug 01, 2023

BUY
$76.01 - $86.7 $40,817 - $46,557
537 Added 2.56%
21,544 $1.66 Million
Q1 2023

Apr 18, 2023

BUY
$77.31 - $88.08 $573,021 - $652,848
7,412 Added 54.52%
21,007 $1.74 Million
Q4 2022

Jan 31, 2023

SELL
$62.32 - $89.47 $573,406 - $823,213
-9,201 Reduced 40.36%
13,595 $1.17 Million
Q3 2022

Oct 19, 2022

BUY
$59.54 - $68.01 $516,747 - $590,258
8,679 Added 61.48%
22,796 $1.41 Million
Q2 2022

Jul 18, 2022

BUY
$57.72 - $65.01 $30,245 - $34,065
524 Added 3.85%
14,117 $873,000
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $787,306 - $986,579
13,593 New
13,593 $808,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Empirical Asset Management, LLC Portfolio

Follow Empirical Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Asset Management, LLC with notifications on news.